ANI Pharma Inc Exchange Agreements

17 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Confidential Materials Omitted and FiledSeparately with the Securities and Exchange Commission Pursuant to a Request for Confidential Treatment under Rule 406 under theSecurities...
Exchange Agreements
ANI Pharma Inc
Pharmaceuticals
2015
Confidential Materials Omitted and FiledSeparately with the Securities and Exchange Commission Pursuant to a Request for Confidential Treatment under Rule 406 under theSecurities...
Exchange Agreements
ANI Pharma Inc
Pharmaceuticals
NJ
2017
Confidential Materials Omitted and FiledSeparately with the Securities and Exchange Commission Pursuant to a Request for Confidential Treatment under Rule 406 under theSecurities...
Exchange Agreements
ANI Pharma Inc
Pharmaceuticals
NY
2017
Confidential Materials Omitted and FiledSeparately with the Securities and Exchange Commission Pursuant to a Request for Confidential Treatment under Rule 406 under theSecurities...
Exchange Agreements
ANI Pharma Inc
Pharmaceuticals
NJ
2016
Confidential Materials Omitted and FiledSeparately with the Securities and Exchange Commission Pursuant to a Request for Confidential Treatment under Rule 406 under theSecurities...
Exchange Agreements
ANI Pharma Inc
Pharmaceuticals
DE
2016
Confidential Materials Omitted and FiledSeparately with the Securities and Exchange Commission Pursuant to a Request for ConfidentialTreatment under Rule 406 under the Securities...
Exchange Agreements
ANI Pharma Inc
Pharmaceuticals
NY
2015
Confidential Materials Omitted and FiledSeparately with the Securities and Exchange Commission Pursuant to a Request for Confidential Treatment under Rule 406 under the Securities...
Exchange Agreements
ANI Pharma Inc
Pharmaceuticals
NY
2014
Confidential Materials Omitted and Filed Separately with the Securities and Exchange Commission Pursuant to a Request for Confidential Treatment under Rule 406 under the...
Exchange Agreements
ANI Pharma Inc
Pharmaceuticals
WI
2012
Confidential Materials Omitted and Filed Separately with the Securities and Exchange Commission Pursuant to a Request for Confidential Treatment under Rule 406 under the...
Exchange Agreements
ANI Pharma Inc
Pharmaceuticals
WI
2012
Confidential Materials Omitted and Filed Separately with the Securities and Exchange Commission Pursuant to a Request for Confidential Treatment under Rule 406 under the...
Exchange Agreements
ANI Pharma Inc
Pharmaceuticals
OH
2012
Confidential Materials Omitted and Filed Separately with the Securities and Exchange Commission Pursuant to a Request for Confidential Treatment under Rule 406 under the...
Exchange Agreements
ANI Pharma Inc
Pharmaceuticals
DE
2012
Confidential Materials Omitted and Filed Separately with the Securities and Exchange Commission Pursuant to a Request for Confidential Treatment under Rule 406 under the...
Exchange Agreements
ANI Pharma Inc
Pharmaceuticals
NY
2012
Confidential Materials Omitted and Filed Separately with the Securities and Exchange Commission Pursuant to a Request for Confidential Treatment under Rule 406 under the...
Exchange Agreements
ANI Pharma Inc
Pharmaceuticals
2012
Confidential Materials Omitted and Filed Separately with the Securities and Exchange Commission Pursuant to a Request for Confidential Treatment under Rule 406 under the...
Exchange Agreements
ANI Pharma Inc
Pharmaceuticals
NY
2012
BIOSANTE PHARMACEUTICALS, INC. SECURITIES EXCHANGE AGREEMENT FEBRUARY 15, 2012
Exchange Agreements
ANI Pharma Inc
Pharmaceuticals
NY
2012
BIOSANTE PHARMACEUTICALS, INC. SECURITIES EXCHANGE AGREEMENT FEBRUARY 7, 2012
Exchange Agreements
ANI Pharma Inc
Pharmaceuticals
NY
2012
LICENSE AGREEMENT between PERMATEC TECHNOLOGIE, AG and BIOSANTE PHARMACEUTICALS, INC. [Portions of this Exhibit have been omitted pursuant to a request for confidentiality under...
Exchange Agreements
ANI Pharma Inc
Pharmaceuticals
WY
2011